Top Markets
#1 Islamic Coin Islamic Coin +155.70%
#2 Siren Siren +35.79%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.01%
#4 Wiki Cat Wiki Cat +25.73%
#5 PulseChain PulseChain +16.92%
#6 The Grays Currency The Grays Currency +16.67%
#7 Arowana Arowana +16.56%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.13%
#9 Cysic Cysic +15.05%
#10 Ribbita by Virtuals Ribbita by Virtuals +14.90%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
GridAI Technologies Corp. GridAI Technologies Corp.

GridAI Technologies Corp.

GRDX
Rank in Stocks #31271
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical... GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
Share Price
$4.02
Market Cap
$13.51M
Change (1 day)
1.77%
Change (1 year)
86.11%
Country
US
Trade GridAI Technologies Corp. (GRDX)

Category

Healthcare
Revenue for GridAI Technologies Corp. (GRDX)
Revenue in Aug 2026 TTM: 0
According to GridAI Technologies Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for GridAI Technologies Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR